Abstract
Gentamicin is a member of aminoglycoside group of broad spectrum antibiotics. It impairs protein synthesis by binding to A site of the 30S subunit of bacterial ribosomes. One of the main side effects of this drug is nephrotoxicity. The drug is known to bind to calreticulin, a chaperone essential for the folding of glycosylated proteins. We provide a detailed structural insight of the calreticulin-gentamicin complex by molecular modeling and the binding of the drug in the presence of explicit solvent was analyzed by molecular dynamics simulation. The gentamicin molecule binds to the lectin site of the calreticulin and lies in the concave channel formed by the long beta sheets. It makes interactions with residues Tyr109, Asp125, Asp135, Asp317 and Trp319 which are crucial for the chaperone function of the calreticulin. The superimposing of the modeled complex with the only available crystal structure complex of calreticulin with a tetrasaccharide (Glc1Man3) shows interesting features. First, the rings of the gentamicin occupy the positions of glucose and the first two mannose sugars of the tetrasaccharide molecule. Second, the oxygen atoms of the glycosidic linkage of these two ligands have a positional deviation of 1.3 Ǻ. The predicted binding constant of 16.9 μM is in accordance with the previous kinetic study experiments. The details therefore, strongly implicate gentamicin as a competitive inhibitor of sugar binding with calreticulin.
Similar content being viewed by others
Abbreviations
- ABNR:
-
Adopted basis set Newton-Raphson
- CHARMM:
-
Chemistry at Harvard molecular mechanics
- PROCHECK:
-
Protein structure check
- PDB:
-
Protein Data Bank
- r.m.s:
-
root mean square
- MMFF:
-
Merck molecular force field
References
Rea RS, Capitano B (2007) Semin Respir Crit Care Med 28:596–603
Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME (2009) Int J Antimicrob Agents 33:201–205
Davies J, Davis BD (1968) J Biol Chem 243:3312–3316
Oliveira JF, Silva CA, Barbieri CD, Oliveira GM, Zanetta DM et al. (2009) Antimicrob Agents Chemother 53:2887–2891
Quiros Y, Vicente-Vicente L, Morales AI, López-Novoa JM, López-Hernández FJ (2011) Toxicol Sci 119:245–256
Martínez-Salgado C, López-Hernández FJ, López-Novoa JM (2007) Toxicol Appl Pharmacol 223:86–98
Servais H, Ortiz A, Devuyst O, Denamur S, Tulkens PM et al. (2008) Apoptosis 13:11–32
Walker PD, Barri Y, Shah SV (1999) Ren Fail 21:433–442
Whelton A (1979) Prog Clin Biol Res 35:33–41
Morales AI, Arévalo M, Pérez-Barriocanal F (2000) Nefrologia 20:408–414
Horibe T, Matsui H, Tanaka M, Nagai H, Yamaguchi Y et al. (2004) Biochem Biophys Res Commun 323:281–287
Balakumar P, Rohilla A, Thangathirupathi A (2010) Pharmacol Res 62:179–186
Koslov G, Pocanschi CL, Rosenauer A, Bastos-Aristizabal S, Gorelik A et al. (2010) J Biol Chem 285:38612–38620
Accelrys Software Inc (2003) Cerius2 modeling environment, release 4.7. Accelrys Software Inc, San Diego
Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) J Comput Chem 4:187–217
Momany FA, Rone R (1992) J Comput Chem 13:888–900
Halgren TA (1996) J Comput Chem 17:490–519
Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) J Mol Graph Model 21:289–307
Mayo SL, Olafson BD, Goddard WA III (1990) J Phys Chem 94:8897–8909
Krammer A, Kirchhoff PD, Jiang X, Venkatachalam CM, Waldman M (2005) J Mol Graph Model 23:395–407
Sönnichsen B, Füllekrug J, Van Nguyen P, Diekmann W, Robinson DG, Mieskes G (1994) J Cell Sci 107:2705–2717
Ware FE, Vassilakos A, Peterson PA, Jackson MR, Lehrman MA, Williams DB (1995) J Biol Chem 270:4697–4704
Spiro RG, Zhu Q, Bhoyroo V, Soling HD (1996) J Biol Chem 271:11588–11594
Vassilakos A, Cohen Doyle MF, Peterson PA, Jackson MR, Williams DB (1996) EMBO J 15:1495–1506
Kapoor M, Srinivas H, Kandiah E, Gemma E, Ellgaard L et al. (2003) J Biol Chem 278:6194–6200
Thomson SP, Williams DB (2005) Cell Stress Chaperones 10:242–251
Gopalakrishnapai J, Gupta G, Karthikeyan T, Sinha S, Kandiah E et al. (2006) Biochem Biophys Res Commun 351:14–20
Kapoor M, Ellgaard L, Gopalakrishnapai J, Schirra C, Gemma E et al. (2004) Biochemistry 43:97–106
Schrag JD, Bergeron JJ, Li Y, Borisova S, Hahn M et al. (2001) Mol Cell 8:633–644
Das U, Hariprasad G, Ethayathulla AS, Manral P, Das TK et al. (2007) PLoS One 2:e1176
Kaufman RJ (1999) Genes Dev 13:1211–1233
Malhotra JD, Kaufman RJ (2007) Antioxid Redox Signal 9:2277–2293
Yoshida H (2007) FEBS J 274:630–658
Kitamura M (2008) Clin Exp Nephrol 12:317–325
Peyrou M, Hanna PE, Cribb AE (2007) Toxicol Sci 99:346–353
Tablan OC, Reyes MP, Rintelmann WF, Lerner AM (1984) J Infect Dis 149:257–263
Gregersen N, Bross P (2010) Mol Biol 648:3–23
Miyazaki T, Sagawa R, Honma T, Noguchi S, Harada T, Komatsuda A et al. (2004) J Biol Chem 279:17295–17300
Yamamoto S, Nakano S, Owari K, Fuziwara K, Ogawa N et al. (2010) FEBS Lett 584:645–651
Hsu DZ, Li YH, Chu PY, Periasamy S, Liu MY (2011) Antimicrob Agents Chemother 55:2532–2536
Patel MB, Deshpande S, Shah G (2011) Ren Fail 33:341–347
Knauer SK, Heinrich UR, Bier C, Habtemichael N, Docter D et al. (2010) Cell Death Dis 1e51
Chen YC, Chen CH, Hsu YH, Chen TH, Sue YM et al. (2011) Eur J Pharmacol 658:213–218
Muthuraman A, Singla SK, Rana A, Singh A, Sood S (2011) Yakugaku Zasshi 131:437–443
Acknowledgments
The ‘Pool Officer fellowship’ to GH from the Council of Scientific and Industrial Research is acknowledged. The financial support given to the Biomedical Informatics Center at the institute by the Indian Council of Medical Research, Government of India, is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
Gururao Hariprasad and Manoj Kumar have contributed equally in the paper
Electronic supplementary material
Below is the link to the electronic supplementary material.
Fig. SI
Sequence homology studies of calreticulin from different species within the mammalian group. Amino acid numbers are given at the end of every sequence block. The mouse calreticulin sequence whose structure is considered for the docking studies is shown in green. % identity and sequence accession numbers are given at the end of the respective sequences. The sequences are of mouse, Mus muscullus (Mm); rat, Rattus norvegius (Rn), rabbit, Oryctolagus cuniculus (Oc), human, Homo sapiens (Hs); pig, Sus scrofa (Ss) and cow, Bos taurus (Bt). ‘*’ are marked for identical residues, ‘:’ are marked for conserved residues and ‘.’ are marked for semi-conserved residues. The conserved cysteines are shown in yellow and the residues making interactions with the sugar in the crystal structure complex (PDB ID: 3O0W) are shown in bold. The residues that have been removed from the protein are shown in gray. A few dashes are introduced to enhance similarities. (JPEG 291 kb)
Rights and permissions
About this article
Cite this article
Hariprasad, G., Kumar, M., Rani, K. et al. Aminoglycoside induced nephrotoxicity: molecular modeling studies of calreticulin-gentamicin complex. J Mol Model 18, 2645–2652 (2012). https://doi.org/10.1007/s00894-011-1289-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-011-1289-8